ZLZoe Lung

Zoe Lung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zoe Lung has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Confined cell migration: Insights from in vitro and in silico methodologies

    by Wyatt Quinones, Jackson Huse, Dylan A. Goodin, Zoe Lung, Landon Teer, Hermann B. Frieboes, Joseph Chen

    Cell migration is an essential biological process involved in development, wound healing, immune response, and cancer metastasis. Recent advances in imaging techniques in vivo have identified confined cell migration as a critical type of locomotion through tissues and vascular tracks. In particular, confined cell migration is crucial in cancer invasion and metastasis, as tumor infiltration necessitates cell migration through confined pores in tissue (1–20 μm) and vascular components (<5 μm). Although cell migration from a biological perspective has been extensively reviewed, recent developments in bioengineering tools such as three-dimensional in vitro models and computational modeling have opened new possibilities to study confined migration in normal development and in disease. This review focuses on in vitro bioengineered platforms and mathematical models developed to study the mechanisms of confined migration. We anticipate that further development of these bioengineered platform technologies, coupled with advances in computational modeling, including multi-scale models and machine learning, will be pivotal to facilitating mechanistic testing and evaluation of therapeutic strategies effectively targeting wound healing and cancer metastasis.

  • Open Access

    Structure–Activity Relationships of N-Acyl Dopamines in Inhibiting Myofibroblast Transdifferentiation of Retinal Pigment Epithelial Cells

    by Dandan Zhao, Vishaka Motheramgari, Riley Freudenberger, Sarah H. Shrader, Lucy J. Sloan, Zoe Lung, Wei Wang, Shigeo Tamiya, Zhao-Hui Song

    Aberrant wound healing in the retina can manifest as proliferative vitreoretinopathy (PVR), which involves the myofibroblast transdifferentiation of retinal pigment epithelial (RPE) cells. In this study, experiments were conducted to examine the structure–activity relationships of endocannabinoid-like compounds, N-acyl dopamines, on the myofibroblast transdifferentiation of RPE cells. The collagen matrix contraction assay was used to assess myofibroblast function. Western blot analysis and immunocytochemistry techniques were used to evaluate myofibroblast markers. N-palmitoyl dopamine (PALDA), N-oleoyl dopamine (OLDA), and N-arachidonoyl dopamine (NADA), in a concentration-dependent manner, inhibited contraction of collagen matrices mediated by either primary porcine RPE cells treated with TGF-β2, or human RPE cells treated with TGF-β2 plus TNFα (TNT). The rank order of potency was PLDA = OLDA > NADA. In contrast, the substitution of dopamine with other polar head groups led to a complete loss of their ability to inhibit myofibroblast transdifferentiation. Western blot analysis demonstrated that PALDA, OLDA, and NADA down-regulated the myofibroblast markers fibronectin and α-SMA. Immunocytochemistry experiments showed that these N-acyl dopamines reduced the incorporation of α-SMA into F-actin stress fibers. Overall, these structure–activity relationship studies demonstrate that the dopamine head group is crucial for N-acyl dopamine to inhibit myofibroblast transdifferentiation of RPE cell, whereas the fatty acid side chain determines the potency of it. This study points to the potential of N-acyl dopamines as a novel class of therapeutic agents for treating retinal fibrotic conditions, such as PVR.